Skip to content

Clinical trials

Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Clear all

1,117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20017
20027
20035
200417
200522
200628
200720
200829
200934
201034
201128
201247
201343
201453
201551
201650
201749
201870
201949
202067
202166
202270
202352
202461
202556
202659

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed596
Recruiting155
Terminated122
Unknown status85
Active, not recruiting57
Not yet recruiting43
Withdrawn42
Enrolling by invitation10
Available3
No longer available2
Temporarily not available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)61
Assistance Publique - Hôpitaux de Paris48
St. Jude Children's Research Hospital45
Children's Hospital Medical Center, Cincinnati30
Emory University28
Pfizer27
Duke University25
Novartis Pharmaceuticals22
UCSF Benioff Children's Hospital Oakland14
University of Illinois at Chicago14

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell1,117
Vaso-Occlusive Crises88
Thalassemia78
beta-Thalassemia58
Hematologic Diseases57
Hemoglobinopathies54
Pain54
Anemia41
Acute Chest Syndrome34
Sickle Cell Trait28

Trials

Showing 1 to 25 of 1,117. Each trial links to its page on Pharma Observatory.

1,017 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.